AMERICAN DIABETES ASSOCIATION;
AWARDS AND PRIZES;
BLOOD ANALYSIS;
BLOOD GLUCOSE MONITORING;
DIABETES MELLITUS;
FEVER;
GLUCOSE BLOOD LEVEL;
GLYCATION;
HEALTH CARE ORGANIZATION;
HEMOGLOBIN BLOOD LEVEL;
HUMAN;
LIFESTYLE MODIFICATION;
MEDICAL INFORMATION;
MEDICAL LITERATURE;
SHORT SURVEY;
AWARDS AND PRIZES;
HEMOGLOBIN A, GLYCOSYLATED;
HUMANS;
SOCIETIES, MEDICAL;
UNITED STATES;
Structure of haemoglobin: A three-dimensional Fourier synthesis at 5.5-A. resolution, obtained by X-ray analysis
Perutz MF, Rossmann MG, Cullis AF, Muirhead H, Will G, North ACT. Structure of haemoglobin: a three-dimensional Fourier synthesis at 5.5-A. resolution, obtained by X-ray analysis. Nature 1960;185:416-422
Synthesis of hemoglobin A1C in normal and diabetic mice: Potential model of basement membrane thickening
Koenig RJ, Cerami A. Synthesis of hemoglobin A1C in normal and diabetic mice: potential model of basement membrane thickening. Proc Natl Acad Sci U S A 1975;72:3687-3691
Correlation of glucose regulation and hemoglobin A1C in diabetes mellitus
Koenig RJ, Peterson CM, Jones RL, Saudek C, Lehrman M, Cerami A. Correlation of glucose regulation and hemoglobin A1C in diabetes mellitus. N Engl J Med 1976; 295:417-420
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
The Diabetes Control and Complications Trial Research Group
The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
UK Prospective Diabetes Study (UKPDS) Group
UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-853